{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T18:14:56Z","timestamp":1760984096330},"reference-count":52,"publisher":"American Association for Cancer Research (AACR)","issue":"6","content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2011,6,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Patients with Barrett's esophagus (BE) and dysplasia are candidates for chemopreventive strategies to reduce cancer risk. We determined the effects of difluoromethylornithine (DMFO) on mucosal polyamines, gene expression, and histopathology in BE. Ten patients with BE and low-grade dysplasia participated in a single-arm study of DFMO (0.5 g\/m2\/d) given continuously for 6 months. Esophagoscopy with biopsies was conducted at baseline, 3, 6, and 12 months. Dysplasia was graded by a gastrointestinal pathologist. Audiology was assessed (at baseline and at 6 months). Mucosal polyamines were measured by high-performance liquid chromatography. Microarray-based gene expression was analyzed using a cDNA two-color chip. DFMO suppressed levels of the polyamines putrescine (P = 0.02) and spermidine (P = 0.02) and the spermidine\/spermine ratio (P &amp;lt; 0.01) in dysplastic BE (6 months vs. baseline) that persisted at 6 months following drug cessation. Among the top 25 modulated genes, we found those regulating p53-mediated cell signaling (RPL11), cell-cycle regulation (cyclin E2), and cell adhesion and invasion (Plexin1). DFMO downregulated Kr\u00fcppel-like factor 5 (KLF5), a transcription factor promoting cell proliferation, and suppressed RFC5 whose protein interacts with proliferating cell nuclear antigen. Histopathology showed regression of dysplasia (n = 1), stable disease (n = 8), and progression to high-grade dysplasia (n = 1). Polyamines were suppressed in the responder to a greater extent than in stable cases. DFMO was well tolerated, and one patient had subclinical, unilateral ototoxicity. DFMO suppressed mucosal polyamines and modulated genes that may be mechanistically related to its chemopreventive effect. Further study of DFMO for the chemoprevention of esophageal cancer in BE patients is warranted. Cancer Prev Res; 4(6); 829\u201339. \u00a92011 AACR.<\/jats:p>","DOI":"10.1158\/1940-6207.capr-10-0243","type":"journal-article","created":{"date-parts":[[2011,6,3]],"date-time":"2011-06-03T05:11:58Z","timestamp":1307077918000},"page":"829-839","update-policy":"http:\/\/dx.doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Evaluation of Difluoromethylornithine for the Chemoprevention of Barrett's Esophagus and Mucosal Dysplasia"],"prefix":"10.1158","volume":"4","author":[{"given":"Frank A.","family":"Sinicrope","sequence":"first","affiliation":[{"name":"Authors' Affiliations:\u20081Mayo Clinic, Rochester, Minnesota; 2MD Anderson Cancer Center, Houston, Texas; 3National Cancer Institute, Bethesda, Maryland; and 4Arizona Cancer Center, Tucson, Arizona"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Russell","family":"Broaddus","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Mayo Clinic, Rochester, Minnesota; 2MD Anderson Cancer Center, Houston, Texas; 3National Cancer Institute, Bethesda, Maryland; and 4Arizona Cancer Center, Tucson, Arizona"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nina","family":"Joshi","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Mayo Clinic, Rochester, Minnesota; 2MD Anderson Cancer Center, Houston, Texas; 3National Cancer Institute, Bethesda, Maryland; and 4Arizona Cancer Center, Tucson, Arizona"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eugene","family":"Gerner","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Mayo Clinic, Rochester, Minnesota; 2MD Anderson Cancer Center, Houston, Texas; 3National Cancer Institute, Bethesda, Maryland; and 4Arizona Cancer Center, Tucson, Arizona"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth","family":"Half","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Mayo Clinic, Rochester, Minnesota; 2MD Anderson Cancer Center, Houston, Texas; 3National Cancer Institute, Bethesda, Maryland; and 4Arizona Cancer Center, Tucson, Arizona"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilan","family":"Kirsch","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Mayo Clinic, Rochester, Minnesota; 2MD Anderson Cancer Center, Houston, Texas; 3National Cancer Institute, Bethesda, Maryland; and 4Arizona Cancer Center, Tucson, Arizona"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"Lewin","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Mayo Clinic, Rochester, Minnesota; 2MD Anderson Cancer Center, Houston, Texas; 3National Cancer Institute, Bethesda, Maryland; and 4Arizona Cancer Center, Tucson, Arizona"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruce","family":"Morlan","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Mayo Clinic, Rochester, Minnesota; 2MD Anderson Cancer Center, Houston, Texas; 3National Cancer Institute, Bethesda, Maryland; and 4Arizona Cancer Center, Tucson, Arizona"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Waun Ki","family":"Hong","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Mayo Clinic, Rochester, Minnesota; 2MD Anderson Cancer Center, Houston, Texas; 3National Cancer Institute, Bethesda, Maryland; and 4Arizona Cancer Center, Tucson, Arizona"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1086","published-online":{"date-parts":[[2011,6,1]]},"reference":[{"key":"2022060816060323600_bib1","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1111\/j.1572-0241.2008.01835.x","article-title":"Updated guidelines 2008 for the diagnosis, surveillance and therapy of Barrett's esophagus","volume":"103","author":"Wang","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"2022060816060323600_bib2","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1093\/jnci\/dji024","article-title":"The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence","volume":"97","author":"Pohl","year":"2005","journal-title":"J Natl Cancer Inst"},{"key":"2022060816060323600_bib3","doi-asserted-by":"crossref","first-page":"225","DOI":"10.3322\/caac.20006","article-title":"Cancer statistics 2009","volume":"59","author":"Jemal","year":"2009","journal-title":"CA Cancer J Clin"},{"key":"2022060816060323600_bib4","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1053\/j.gastro.2005.08.053","article-title":"Prevalence of Barrett's esophagus in the general population: an endoscopic study","volume":"129","author":"Ronkainen","year":"2005","journal-title":"Gastroenterology"},{"key":"2022060816060323600_bib5","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1038\/nrc1454","article-title":"Polyamines and cancer: old molecules, new understanding","volume":"4","author":"Gerner","year":"2004","journal-title":"Nat Rev Cancer"},{"key":"2022060816060323600_bib6","first-page":"945","article-title":"Development of difluoromethylornithine (DFMO) as a chemoprevention agent","volume":"5","author":"Meyskens","year":"1999","journal-title":"Clin Cancer Res"},{"key":"2022060816060323600_bib7","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/jcb.240560905","article-title":"Preclinical efficacy evaluation of potential chemopreventive agents in animal carcinogenesis models: methods and results from the NCI Chemoprevention Drug Development Program","volume":"20","author":"Steele","year":"1994","journal-title":"J Cell Biochem Suppl"},{"key":"2022060816060323600_bib8","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1093\/jnci\/90.16.1212","article-title":"Effect of alpha-difluoromethylornithine on rectal mucosal levels of polyamines in a randomized, double-blinded trial for colon cancer prevention","volume":"90","author":"Meyskens","year":"1998","journal-title":"J Natl Cancer Inst"},{"key":"2022060816060323600_bib9","first-page":"3288","article-title":"Ornithine decarboxylase and polyamine levels in columnar upper gastrointestinal mucosae in patients with Barrett's esophagus","volume":"48","author":"Garewal","year":"1988","journal-title":"Cancer Res"},{"key":"2022060816060323600_bib10","first-page":"5380","article-title":"Alpha-difluoromethylornithine inhibits N-nitrosomethylbenzylamine-induced esophageal carcinogenesis in zinc-deficient rats: effects on esophageal cell proliferation and apoptosis","volume":"58","author":"Fong","year":"1998","journal-title":"Cancer Res"},{"key":"2022060816060323600_bib11","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1111\/j.1572-0241.2008.02129.x","article-title":"Chemoprevention and Barrett's esophagus: decisions, decisions","volume":"103","author":"Falk","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"2022060816060323600_bib12","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/S1091-255X(01)80031-7","article-title":"Upregulation of ornithine decarboxylase mRNA expression in Barrett's esophagus and Barrett's-associated adenocarcinoma","volume":"5","author":"Brabender","year":"2001","journal-title":"J Gastrointest Surg"},{"key":"2022060816060323600_bib13","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1158\/1940-6207.CAPR-08-0042","article-title":"Difluoromethylornithine plus sulindac for the prevention of sporadic colorectal adenomas: a randomized placebo-controlled, double-blind trial","volume":"1","author":"Meyskens","year":"2008","journal-title":"Cancer Prev Res"},{"key":"2022060816060323600_bib14","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1158\/1940-6207.CAPR-08-0074","article-title":"Longitudinal assessment of air conduction audiograms in a phase III clinical trial of difluoromethylornithine and sulindac for prevention of sporadic colorectal adenomas","volume":"1","author":"McLaren","year":"2008","journal-title":"Cancer Prev Res"},{"key":"2022060816060323600_bib15","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/j.1442-2050.2008.00813.x","article-title":"Surveillance history of endoscopically treated patients with early Barrett's neoplasia: nonadherence to the Seattle biopsy protocol leads to sampling error","volume":"21","author":"Peters","year":"2008","journal-title":"Dis Esophagus"},{"key":"2022060816060323600_bib16","author":"American Speech-Language-Hearing Association"},{"key":"2022060816060323600_bib17","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1097\/AUD.0b013e318181ad99","article-title":"Factors affecting sensitivity of distortion-product otoacoustic emissions to ototoxic hearing loss","volume":"29","author":"Reavis","year":"2008","journal-title":"Ear Hear"},{"key":"2022060816060323600_bib18","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1200\/JCO.2006.07.9723","article-title":"Early changes in auditory function as a result of platinum chemotherapy: use of extended high-frequency audiometry and evoked distortion product otoacoustic emissions","volume":"25","author":"Knight","year":"2007","journal-title":"J Clin Oncol"},{"key":"2022060816060323600_bib19","first-page":"131","article-title":"Garewal HS, Gerner EW. Polyamine contents in rectal and buccal mucosae in humans treated with oral difluoromethylornithine","volume":"1","author":"Boyle","year":"1992","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2022060816060323600_bib20","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1073\/pnas.87.5.1663","article-title":"Amplified RNA synthesized from limited quantities of heterogeneous cDNA","volume":"87","author":"Van Gelder","year":"1990","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2022060816060323600_bib21","author":"Center for Cancer Research","year":"2010  10"},{"key":"2022060816060323600_bib22","article-title":"BRB-ArrayTools, Version 3.2 User's Manual","author":"Simon","year":"2004"},{"key":"2022060816060323600_bib23","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1158\/1055-9965.EPI-04-0866","article-title":"Celecoxib treatment alters the gene expression profile of normal colonic mucosa","volume":"15","author":"Glebov","year":"2006","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2022060816060323600_bib24","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1093\/bioinformatics\/bti105","article-title":"Normalization of two-channel microarray experiments: a semiparametric approach","volume":"21","author":"Eckel","year":"2005","journal-title":"Bioinformatics"},{"key":"2022060816060323600_bib25","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/ncb1858","article-title":"Absence of nucleolar disruption after impairment of 40S ribosome biogenesis reveals an rpL11-translation-dependent mechanism of p53 induction","volume":"11","author":"Fumagalli","year":"2009","journal-title":"Nat Cell Biol"},{"key":"2022060816060323600_bib26","doi-asserted-by":"crossref","first-page":"e4152","DOI":"10.1371\/journal.pone.0004152","article-title":"Loss of ribosomal protein L11 affects zebrafish embryonic development through a p53-dependent apoptotic response","volume":"4","author":"Chakraborty","year":"2009","journal-title":"PLoS One"},{"key":"2022060816060323600_bib27","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.molcel.2009.01.015","article-title":"TAF12 recruits Gadd45a and the nucleotide excision repair complex to the promoter of rRNA genes leading to active DNA demethylation","volume":"33","author":"Schmitz","year":"2009","journal-title":"Mol Cell"},{"key":"2022060816060323600_bib28","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.jprot.2009.01.002","article-title":"Human defensins as cancer biomarkers and antitumour molecules","volume":"72","author":"Droin","year":"2009","journal-title":"J Proteomics"},{"key":"2022060816060323600_bib29","doi-asserted-by":"crossref","first-page":"2597","DOI":"10.1002\/(SICI)1097-0142(19991215)86:12<2597::AID-CNCR3>3.0.CO;2-0","article-title":"Expression of cyclin E in dysplasia, carcinoma, and nonmalignant lesions of Barrett esophagus","volume":"86","author":"Sarbia","year":"1999","journal-title":"Cancer"},{"key":"2022060816060323600_bib30","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1046\/j.1365-2559.2001.01279.x","article-title":"Expression of cell cycle regulatory proteins in the multistep process of oesophageal carcinogenesis: stepwise over-expression of cyclin E and p53, reduction of p21(WAF1\/CIP1) and dysregulation of cyclin D1 and p27(KIP1)","volume":"39","author":"Ohbu","year":"2001","journal-title":"Histopathology"},{"key":"2022060816060323600_bib31","doi-asserted-by":"crossref","first-page":"19040","DOI":"10.1073\/pnas.0702544104","article-title":"Plexin-B1 mutations in prostate cancer","volume":"104","author":"Wong","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2022060816060323600_bib32","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1038\/jid.2010.13","article-title":"Plexin B1 suppresses c-Met in melanoma: a role for plexin B1 as a tumor-suppressor protein through regulation of c-Met","volume":"130","author":"Stevens","year":"2010","journal-title":"J Invest Dermatol"},{"key":"2022060816060323600_bib33","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1093\/jb\/mvj034","article-title":"The post-translational synthesis of a polyamine-derived amino acid, hypusine, in the eukaryotic translation initiation factor 5A (eIF5A)","volume":"139","author":"Park","year":"2006","journal-title":"J Biochem"},{"key":"2022060816060323600_bib34","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1073\/pnas.0509348102","article-title":"Molecular cloning, expression, and structural prediction of deoxyhypusine hydroxylase: a HEAT-repeat-containing metalloenzyme","volume":"103","author":"Park","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2022060816060323600_bib35","doi-asserted-by":"crossref","first-page":"3499","DOI":"10.1073\/pnas.0914307107","article-title":"NudC-like protein 2 regulates the LIS1\/dynein pathway by stabilizing LIS1 with Hsp90","volume":"107","author":"Yang","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2022060816060323600_bib36","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.4161\/cbt.4.11.2090","article-title":"KLF4 and KLF5 regulate proliferation, apoptosis and invasion in esophageal cancer cells","volume":"4","author":"Yang","year":"2005","journal-title":"Cancer Biol Ther"},{"key":"2022060816060323600_bib37","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1111\/j.1349-7006.2003.tb01505.x","article-title":"Identification of genes differentially expressed in a newly isolated human metastasizing esophageal cancer cell line, T.Tn-AT1, by cDNA microarray","volume":"94","author":"Kawamata","year":"2003","journal-title":"Cancer Sci"},{"key":"2022060816060323600_bib38","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1073\/pnas.96.5.1869","article-title":"Studies on the interactions between human replication factor C and human proliferating cell nuclear antigen","volume":"96","author":"Zhang","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2022060816060323600_bib39","doi-asserted-by":"crossref","first-page":"5609","DOI":"10.1158\/0008-5472.CAN-08-0884","article-title":"Thymoquinone triggers inactivation of the stress response pathway sensor CHEK1 and contributes to apoptosis in colorectal cancer cells","volume":"68","author":"Gali-Muhtasib","year":"2008","journal-title":"Cancer Res"},{"key":"2022060816060323600_bib40","doi-asserted-by":"crossref","first-page":"3831","DOI":"10.1038\/sj.onc.1202758","article-title":"Cellular functions of TC10, a Rho family GTPase: regulation of morphology, signal transduction and cell growth","volume":"18","author":"Murphy","year":"1999","journal-title":"Oncogene"},{"key":"2022060816060323600_bib41","doi-asserted-by":"crossref","first-page":"23287","DOI":"10.1074\/jbc.M201154200","article-title":"The C66W mutation in the deafness dystonia peptide 1 (DDP1) affects the formation of functional DDP1.TIM13 complexes in the mitochondrial intermembrane space","volume":"277","author":"Hofmann","year":"2002","journal-title":"J Biol Chem"},{"key":"2022060816060323600_bib42","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/0016-5085(88)90259-4","article-title":"Ornithine decarboxylase activity in Barrett's esophagus: a potential marker for dysplasia","volume":"94","author":"Garewal","year":"1988","journal-title":"Gastroenterology"},{"key":"2022060816060323600_bib43","first-page":"325","article-title":"Gastrointestinal tissue polyamine contents of patients with Barrett's esophagus treated with alpha-difluoromethylornithine","volume":"3","author":"Gerner","year":"1994","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2022060816060323600_bib44","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/j.jada.2007.03.012","article-title":"Development of a polyamine database for assessing dietary intake","volume":"107","author":"Zoumas-Morse","year":"2007","journal-title":"J Am Diet Assoc"},{"key":"2022060816060323600_bib45","doi-asserted-by":"crossref","first-page":"G517","DOI":"10.1152\/ajpgi.00169.2010","article-title":"Polyamine transport is mediated by both endocytic and solute carrier transport mechanisms in the gastrointestinal tract","volume":"299","author":"Uemura","year":"2010","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"2022060816060323600_bib46","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1053\/j.gastro.2010.06.005","article-title":"Levels of rectal mucosal polyamines and prostaglandin E2 predict ability of DFMO and sulindac to prevent colorectal adenoma","volume":"139","author":"Thompson","year":"2010","journal-title":"Gastroenterology"},{"key":"2022060816060323600_bib47","first-page":"15","article-title":"P53, cyclin-dependent kinase and abnormal amplification of centrosomes","volume":"1786","author":"Fukasawa","year":"2008","journal-title":"Biochim Biophys Acta"},{"key":"2022060816060323600_bib48","doi-asserted-by":"crossref","first-page":"G1784","DOI":"10.1152\/ajpgi.00541.2006","article-title":"Overexpression of Kruppel-like factor 5 in esophageal epithelia in vivo leads to increased proliferation in basal but not suprabasal cells","volume":"292","author":"Goldstein","year":"2007","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"2022060816060323600_bib49","doi-asserted-by":"crossref","first-page":"11026","DOI":"10.1158\/0008-5472.CAN-05-1339","article-title":"Interaction between polyamines and the mitogen-activated protein kinase pathway in the regulation of cell cycle variables in breast cancer cells","volume":"65","author":"Hu","year":"2005","journal-title":"Cancer Res"},{"key":"2022060816060323600_bib50","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1111\/j.1572-0241.2003.07666.x","article-title":"Long-term endoscopic surveillance of patients with Barrett's esophagus. Incidence of dysplasia and adenocarcinoma: a prospective study","volume":"98","author":"Conio","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"2022060816060323600_bib51","doi-asserted-by":"crossref","first-page":"3089","DOI":"10.1111\/j.1572-0241.2000.03182.x","article-title":"Optimizing endoscopic biopsy detection of early cancers in Barrett's high-grade dysplasia","volume":"95","author":"Reid","year":"2000","journal-title":"Am J Gastroenterol"},{"key":"2022060816060323600_bib52","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.heares.2009.02.008","article-title":"Otoacoustic detection of risk of early hearing loss in ears with normal audiograms: a 3-year follow-up study","volume":"251","author":"Job","year":"2009","journal-title":"Hear Res"}],"container-title":["Cancer Prevention Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerpreventionresearch\/article-pdf\/4\/6\/829\/2249614\/829.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerpreventionresearch\/article-pdf\/4\/6\/829\/2249614\/829.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,8]],"date-time":"2022-06-08T17:30:54Z","timestamp":1654709454000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerpreventionresearch\/article\/4\/6\/829\/49850\/Evaluation-of-Difluoromethylornithine-for-the"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,6,1]]},"references-count":52,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2011,6,1]]},"published-print":{"date-parts":[[2011,6,1]]}},"URL":"https:\/\/doi.org\/10.1158\/1940-6207.capr-10-0243","relation":{},"ISSN":["1940-6207","1940-6215"],"issn-type":[{"value":"1940-6207","type":"print"},{"value":"1940-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,6,1]]}}}